Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment
NCT01227369 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4376
Last updated 2017-06-07
Summary
Quality of Life (QoL) in Korean postmenopausal osteoporosis patients with bisphosphonate treatment
Conditions
- Osteoporosis, Postmenopausal
Interventions
- OTHER
-
OPSAT-Q
A linguistically validated Korean version of OPSAT-Q
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-06-30
- Primary Completion
- 2009-11-30
- Completion
- 2009-11-30
Countries
- South Korea
Study Locations
More Related Trials
-
Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis
NCT00542984 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With Osteoporosis
NCT05067335 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose of Treatment or Prevention of Osteoporosis
NCT05614778 ·Status: COMPLETED
-
Study to Evaluate the Efficacy and Safety of PBK_L2201 in Postmenopausal Women With Osteoporosis
NCT06154187 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With Osteoporosis
NCT02791516 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study of Menopausal Symptom in Patients With Gynecological Malignancy After Oophorectomy
NCT06151028 ·Status: RECRUITING
-
A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis
NCT01292187 ·Status: COMPLETED ·Phase: PHASE2
-
PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)
NCT00515593 ·Status: COMPLETED
-
Satisfaction and Compliance of Risedronate in PMO
NCT00549965 ·Status: COMPLETED ·Phase: PHASE4
-
Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women
NCT00358176 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Pitavastatin on Bone
NCT06359353 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of QL1206 in the Treatment of Postmenopausal Osteoporosis With High Fracture Risk
NCT04128163 ·Status: UNKNOWN ·Phase: PHASE3
-
The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss
NCT00460057 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer
NCT00859703 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Treatment of Postmenopausal Women With Osteoporosis
NCT00543023 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab
NCT01495000 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol
NCT04788290 ·Status: COMPLETED
-
Effect of Vitamin D and Denosumab on Bone Remodelling in Women With Postmenopausal Osteoporosis
NCT05372224 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis
NCT01675297 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Arzoxifene to Treat Korean Women With Osteoporosis
NCT00767299 ·Status: COMPLETED ·Phase: PHASE2
-
Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women
NCT00353080 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women
NCT01904110 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability and Efficacy of MK0773 in Healthy Postmenopausal Women (0773-003)
NCT01011725 ·Status: COMPLETED ·Phase: PHASE1
-
Weekly vs Daily Teriparatide Therapy in Severe Postmenopausal Osteoporosis
NCT01760798 ·Status: UNKNOWN ·Phase: NA
-
BONVIVA(Ibandronate) Injection PMS(Post-marketing Surveillance)
NCT01376102 ·Status: COMPLETED